Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumes, personal hygiene and beauty products, cosmetics, and dermo-cosmetics in Brazil. It sells its products through stores under Panvel brand. The company is also involved in purchasing, selling, brokering, subdividing, leasing, renting, managing and administering its owned and third-party properties. Dimed S.A. Distribuidora de Medica… Read more
Dimed S.A. Distribuidora de Medicamentos (PNVL3) - Total Assets
Latest total assets as of September 2025: R$3.58 Billion BRL
Based on the latest financial reports, Dimed S.A. Distribuidora de Medicamentos (PNVL3) holds total assets worth R$3.58 Billion BRL as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dimed S.A. Distribuidora de Medicamentos - Total Assets Trend (2000–2024)
This chart illustrates how Dimed S.A. Distribuidora de Medicamentos’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dimed S.A. Distribuidora de Medicamentos - Asset Composition Analysis
Current Asset Composition (December 2024)
Dimed S.A. Distribuidora de Medicamentos's total assets of R$3.58 Billion consist of 59.6% current assets and 40.4% non-current assets.
| Asset Category | Amount (BRL) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$74.18 Million | 2.4% |
| Accounts Receivable | R$578.00 Million | 17.1% |
| Inventory | R$1.15 Billion | 34.1% |
| Property, Plant & Equipment | R$1.17 Billion | 34.8% |
| Intangible Assets | R$90.72 Million | 2.7% |
| Goodwill | R$5.95 Million | 0.2% |
Asset Composition Trend (2000–2024)
This chart illustrates how Dimed S.A. Distribuidora de Medicamentos's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dimed S.A. Distribuidora de Medicamentos's current assets represent 59.6% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2024, down from 4.4% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is property, plant & equipment at 34.8% of total assets.
Dimed S.A. Distribuidora de Medicamentos Competitors by Total Assets
Key competitors of Dimed S.A. Distribuidora de Medicamentos based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
PINK:NVSEF
|
USA | $115.49 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
Dimed S.A. Distribuidora de Medicamentos - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Dimed S.A. Distribuidora de Medicamentos generates 1.46x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Dimed S.A. Distribuidora de Medicamentos generates $ 3.12 in net profit.
Dimed S.A. Distribuidora de Medicamentos - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.91 | 1.60 | 2.03 |
| Quick Ratio | 0.90 | 0.63 | 1.18 |
| Cash Ratio | 0.04 | 0.01 | 0.00 |
| Working Capital | R$1.02 Billion | R$ 717.51 Million | R$ 698.78 Million |
Dimed S.A. Distribuidora de Medicamentos - Advanced Valuation Insights
This section examines the relationship between Dimed S.A. Distribuidora de Medicamentos's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.76 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 9.7% |
| Total Assets | R$3.38 Billion |
| Market Capitalization | $166.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dimed S.A. Distribuidora de Medicamentos's assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Dimed S.A. Distribuidora de Medicamentos's assets grew by 9.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Dimed S.A. Distribuidora de Medicamentos (2000–2024)
The table below shows the annual total assets of Dimed S.A. Distribuidora de Medicamentos from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | R$3.38 Billion | +9.75% |
| 2023-12-31 | R$3.08 Billion | +12.60% |
| 2022-12-31 | R$2.73 Billion | +14.79% |
| 2021-12-31 | R$2.38 Billion | +8.51% |
| 2020-12-31 | R$2.19 Billion | +50.27% |
| 2019-12-31 | R$1.46 Billion | +45.97% |
| 2018-12-31 | R$1.00 Billion | +5.28% |
| 2017-12-31 | R$950.17 Million | +15.74% |
| 2016-12-31 | R$820.97 Million | +8.03% |
| 2015-12-31 | R$759.97 Million | +5.66% |
| 2014-12-31 | R$719.27 Million | +19.90% |
| 2013-12-31 | R$599.89 Million | +19.78% |
| 2012-12-31 | R$500.82 Million | +13.27% |
| 2011-12-31 | R$442.15 Million | +17.25% |
| 2010-12-31 | R$377.11 Million | +13.22% |
| 2009-12-31 | R$333.08 Million | +20.79% |
| 2008-12-31 | R$275.75 Million | +8.79% |
| 2007-12-31 | R$253.46 Million | +8.18% |
| 2006-12-31 | R$234.29 Million | +7.71% |
| 2005-12-31 | R$217.51 Million | +20.86% |
| 2004-12-31 | R$179.97 Million | +4.62% |
| 2003-12-31 | R$172.02 Million | +18.46% |
| 2002-12-31 | R$145.21 Million | -7.22% |
| 2001-12-31 | R$156.51 Million | +5.90% |
| 2000-12-31 | R$147.79 Million | -- |